Update on myocarditis in children

Current Opinion in Pediatrics

Volumn 22, Issue 3, 2010, Pages 278-283

  Levine, Marla C ^a   Klugman, Darren ^a   Teach, Stephen J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Children; Diagnosis; Myocarditis; Treatment

Indexed keywords

AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISONE;

CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MYOCARDITIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

BIOPSY; CHILD; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC TESTS, ROUTINE; DISEASE PROGRESSION; HUMANS; MYOCARDITIS;

EID: 77952421913     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32833924d2     Document Type: Review

References (53)

1. Stiller B. Management of myocarditis in children: the current situation. Adv Exp Med Biol 2008; 609:196-215.
2. Karjalainen J, Heikkila J. Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J 1999; 20:1120-1125.
3. Wakafuji S, Okada R. Twenty year autopsy statistics of myocarditis incidence in Japan. Jpn Circ J 1986; 50:1288-1293.
4. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003; 348:1639-1646.
5. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348:1647-1655.
6. Sparrow PJ, Merchant N, Provost YL, et al. CT and MR imaging findings in patients with acquired heart disease at risk for sudden cardiac death. Radiographics 2009; 29:805-823.
7. Noren GR, Staley NA, Bandt CM, Kaplan EL. Occurrence of myocarditis in sudden death in children. J Forensic Sci 1977; 22:188-196.
8. Theleman KP, Kuiper JJ, Roberts WC. Acute myocarditis (predominately lymphocytic) causing sudden death without heart failure. Am J Cardiol 2001; 88:1078-1083.
9. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J 2001; 77:4-10.
10. Vashist S, Singh GK. Acute myocarditis in children: current concepts and management. Curr Treat Options Cardiovasc Med 2009; 11:383-391.
11. Robinson J, Hartling L, Vandermeer B, et al. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 2005:CD004370.
12. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1:3-14.
13. Bowles NE, Bowles KR, Towbin JA. Viral genomic detection and outcome in myocarditis. Heart Fail Clin 2005; 1:407-417.
14. Bohn D, Benson L. Diagnosis and management of pediatric myocarditis. Paediatr Drugs 2002; 4:171-181.
15. Danti M, Sbarbati S, Alsadi N, et al. Cardiac magnetic resonance imaging: diagnostic value and utility in the follow-up of patients with acute myocarditis mimicking myocardial infarction. Radiol Med 2009; 114:229-238.
16. Kuhn B, Shapiro ED, Walls TA, Friedman AH. Predictors of outcome of myocarditis. Pediatr Cardiol 2004; 25:379-384.
17. Kuhl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108:945-950.
18. Bratincsak A, El-Said HG, Bradley JS, Shayan K, Grossfeld PD, Cannavino CR. Fulminant Myocarditis Associated With Pandemic H1N1 Influenza A Virus in Children. J Am Coll Cardiol 2010; 55:928-929.
19. Bohn D. Acute viral myocarditis. Pediatri Crit Care Med 2006; 7:3-24.
20. Shekerdemian L, Bohn D. Acute viral myocarditis:Epidemiology and Pathophysiology. Pediatr Crit Care Med 2006; 7:6.
21. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy: role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997; 61:275-291.
22. Goitein O, Matetzky S, Beinart R, et al. Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography. AJR Am J Roentgenol 2009; 192:254-258.
23. Kishimoto C, Kuribayashi K, Masuda T, et al. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation 1985; 71:1247-1254. (Pubitemid 15036372)
24. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99:1091-1100.
25. Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children. Heart 2006; 92:1269-1273.
26. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998; 97:1802-1809.
27. Krous HF, Ferandos C, Masoumi H, et al. Myocardial inflammation, cellular death, and viral detection in sudden infant death caused by SIDS, suffocation, or myocarditis. Pediatr Res 2009; 66:17-21.
28. Freedman SB, Haladyn JK, Floh A, et al. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics 2007; 120:1278-1285.
29. Durani Y, Egan M, Baffa J, et al. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med 2009; 27:942-947.
30. Renko M, Leskinen M,Kontiokari T, et al. Cardiac troponin-l as a screening tool for myocarditis in children hospitalized for viral infection. Acta Paediatr 2009. [Epub ahead of print]
31. Franz WM, Remppis A, Kandolf R, et al. Serum troponin T: diagnostic marker for acute myocarditis. Clin Chem 1996; 42:340-341.
32. Soongswang J, Durongpisitkul K, Ratanarapee S, et al. Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children. Pediatr Cardiol 2002; 23:531-535.
33. Lippi G, Salvagno GL, Guidi GC. Cardiac troponins in pediatric myocarditis. Pediatrics 2008; 121:864; author reply 864-865.
34. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006; 48:2085-2093.
35. Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34:2105-2110.
36. Checchia PA, Kulik TJ. Acute viral myocarditis: Diagnosis. Pediatr Crit Care Med 2006; 7:4.
37. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009; 53:1475-1487. Consensus guidelines that delineate the indications, protocols and diagnostic criteria for the use of cardiac MR in the patient with suspected myocarditis.
38. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109:1250-1258.
39. Vashist S, Woodard PK, Grady M, Singh G. MRI characteristics of acute myocarditis in pediatric patients: patterns and predictors of outcomes [abstract]. St Louis Washington University School of Medicine; 2009.
40. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89:252-257.
41. Kishimoto C, Abelmann WH. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Circ Res 1990; 67:589-598.
42. Camargo PR, Okay TS, Yamamoto L, et al. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int J Cardiol 2009. [Epub ahead of print]
43. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254-2259.
44. Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol 2009. [Epub ahead of print]
45. Feltes TF, Adatia I. Immunotherapies for acute viral myocarditis in the pediatric patient. Pediatr Crit Care Med 2006; 7:S17-S20.
46. Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16:61-68.
47. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004; 89:580-584.
48. Frobel AK, Hulpke-Wette M, Schmidt KG, Laer S. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev 2009:CD007037.
49. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007; 298:1171-1179.
50. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999; 82:226-233.
51. Feldman AM, McNamaraD. Myocarditis. N Engl J Med 2000; 343:1388-1398.
52. Greenwood RD, Nadas AS, Fyler DC. The clinical course of primary myocardial disease in infants and children. Am Heart J 1976; 92:549-560.
53. Daubeney PE, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006; 114:2671-2678.